News
LEXINGTON, MA, USA I July 07, 2025 I Agenus Inc. (Nasdaq: AGEN) a leader in immuno-oncology innovation, today announced that its botensilimab and balstilimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback